Exagen Inc Forecast, price target & analysts
Exagen Inc Target price 2026 - Analyst rating & recommendation
Exagen Inc Classifications & Recommendation
Exagen Inc Price Target
| Target Price | $10.20 |
| Price | $8.72 |
| Potential |
16.97%
register free of charge
|
| Number of Estimates | 8 |
|
8 Analysts have issued a price target Exagen Inc 2027 .
The average Exagen Inc target price is $10.20.
This is
16.97%
register free of charge
$12.60
44.50%
register free of charge
$9.09
4.24%
register free of charge
|
|
| A rating was issued by 12 analysts: 11 Analysts recommend Exagen Inc to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Exagen Inc stock has an average upside potential 2027 of
16.97%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2032
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 66.58 | 74.63 |
| 19.66% | 12.08% | |
| EBITDA Margin | -17.95% | -7.85% |
| 16.15% | 56.26% | |
| Net Margin | -29.96% | -21.19% |
| 10.26% | 29.28% |
9 Analysts have issued a sales forecast Exagen Inc 2026 . The average Exagen Inc sales estimate is
This results in the following potential growth metrics:
8 Analysts have issued an Exagen Inc EBITDA forecast 2026. The average Exagen Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
9 Exagen Inc Analysts have issued a net profit forecast 2026. The average Exagen Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2032
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.93 | -0.65 |
| 12.05% | 30.11% | |
| P/E | negative | |
| EV/Sales | 2.69 |
9 Analysts have issued a Exagen Inc forecast for earnings per share. The average Exagen Inc EPS is
This results in the following potential growth metrics and future valuations:
Current Exagen Inc Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| B. Riley Securities |
Locked
➜
Locked
|
Locked | Aug 05 2026 |
| BTIG |
Locked
➜
Locked
|
Locked | Aug 05 2026 |
| TD Cowen |
Locked
➜
Locked
|
Locked | Aug 05 2026 |
| Roth Capital |
Locked
➜
Locked
|
Locked | Jun 25 2026 |
| BTIG |
Locked
➜
Locked
|
Locked | May 12 2026 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Apr 20 2026 |
| Canaccord Genuity |
Locked
➜
Locked
|
Locked | Mar 11 2026 |
| Analyst Rating | Date |
|---|---|
|
Locked
B. Riley Securities:
Locked
➜
Locked
|
Aug 05 2026 |
|
Locked
BTIG:
Locked
➜
Locked
|
Aug 05 2026 |
|
Locked
TD Cowen:
Locked
➜
Locked
|
Aug 05 2026 |
|
Locked
Roth Capital:
Locked
➜
Locked
|
Jun 25 2026 |
|
Locked
BTIG:
Locked
➜
Locked
|
May 12 2026 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Apr 20 2026 |
|
Locked
Canaccord Genuity:
Locked
➜
Locked
|
Mar 11 2026 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
